Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas and Euroimmune Assays for Determination of Epstein‐Barr Virus Serological Diagnosis

2021 ◽  
Author(s):  
Ozgur Appak ◽  
Muge Hacer Ozkaratas ◽  
Ayca Arzu Sayiner
Keyword(s):  
Epstein Barr Virus ◽  
Serological Diagnosis ◽  
Barr Virus ◽  
Epstein Barr ◽  
Abbott Architect

Comparison of Abbott Architect ® , Siemens Immulite ® , and Diasorin Liaison ® for determination of Epstein–Barr virus serological diagnosis

2018 ◽  
Vol 90 (2) ◽  
pp. 96-101 ◽  
Author(s):  
Catherine François ◽  
Christine Segard ◽  
Maryline Bouvier ◽  
Martine Stefanski ◽  
Christine Pannier ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Serological Diagnosis ◽  
Barr Virus ◽  
Epstein Barr ◽  
Abbott Architect

scholarly journals Comparison of Three Automated Immunoassay Methods for the Determination of Epstein-Barr Virus-Specific Immunoglobulin M

2010 ◽  
Vol 17 (4) ◽  
pp. 559-563 ◽  
Author(s):  
Mario Berth ◽  
Eugene Bosmans
Keyword(s):  
Epstein Barr Virus ◽  
Antibody Test ◽  
Immunoglobulin M ◽  
Nuclear Antigen ◽  
Two Phase ◽  
Barr Virus ◽  
Epstein Barr ◽  
Automated Immunoassay ◽  
A Prospective Study

ABSTRACT In this study we compared the performances of three commercially available Epstein-Barr virus (EBV) immunoglobulin M (IgM) assays on highly automated immunoassay platforms: BioPlex 2200 (Bio-Rad Laboratories), Immulite 2000 (Siemens Healthcare Diagnostics), and Liaison (DiaSorin). As a confirmatory method, immunoblotting was performed. The specificity of the three EBV IgM assays was evaluated by testing 293 selected sera from patients with various infectious and noninfectious diseases. After the exclusion of 30 samples, the specificities were 96.2% for Liaison, 98.1% for Immulite, and 97.0% for BioPlex. For evaluation of the sensitivity, samples from 70 consecutive patients with a positive heterophile antibody test were examined, irrespective of clinical or biological findings. After the exclusion of six samples, the sensitivities were 89.1% for Liaison, 84.4% for Immulite, and 89.1% for BioPlex. Finally, in a prospective study performed with 500 samples obtained from consecutive patients and sent in by general practitioners, we also determined Epstein-Barr nuclear antigen IgG and viral capsid antigen IgG in a two-phase approach. Concordance of the EBV serologic status was 96.2% between Liaison and Immulite, 96.4% between Immulite and BioPlex, and 97.8% between BioPlex and Liaison. The three EBV IgM immunoassays that we evaluated have acceptable and comparable performances.

Chromosome banding, isoenzyme studies and determination of epstein-barr virus DNA content on human burkitt lymphoma/mouse hybrids

1977 ◽  
Vol 20 (6) ◽  
pp. 849-853 ◽  
Author(s):  
Jack Spira ◽  
Susanne Povey ◽  
Francis Wiener ◽  
George Klein ◽  
Maria Andersson-Anvret
Keyword(s):  
Dna Content ◽  
Burkitt Lymphoma ◽  
Epstein Barr Virus ◽  
Chromosome Banding ◽  
Barr Virus ◽  
Epstein Barr

scholarly journals Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs

1993 ◽  
Vol 42 (2-3) ◽  
pp. 301-307 ◽  
Author(s):  
Inge Färber ◽  
Peter Wutzler ◽  
Peter Wohlrabe ◽  
Hans Wolf ◽  
Walter Hinderer ◽  
...  
Keyword(s):  
Infectious Mononucleosis ◽  
Epstein Barr Virus ◽  
Serological Diagnosis ◽  
Barr Virus ◽  
Virus Recombinant ◽  
Epstein Barr
Sign in / Sign up

Export Citation Format

Share Document